Assaf Oron Net Worth

The estimated Net Worth of Assaf Oron is at least $471 millier dollars as of 22 May 2023. Mr. Oron owns over 3,192 units of BiomX Inc stock worth over $10,805 and over the last 5 years he sold PHGE stock worth over $4,038. In addition, he makes $455,692 as Chief Business Officer at BiomX Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Oron PHGE stock SEC Form 4 insiders trading

Assaf has made over 3 trades of the BiomX Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he sold 10,914 units of PHGE stock worth $4,038 on 29 November 2023.

The largest trade he's ever made was selling 10,914 units of BiomX Inc stock on 29 November 2023 worth over $4,038. On average, Assaf trades about 2,425 units every 22 days since 2020. As of 22 May 2023 he still owns at least 10,914 units of BiomX Inc stock.

You can see the complete history of Mr. Oron stock trades at the bottom of the page.

Assaf Oron biography

Assaf Oron serves as Chief Business Officer of the Company. He has served as the Chief Business Officer of the Company since October 2019. Mr. Oron served as Chief Business Officer of BiomX from January 2017 to October 2019. Prior to this position, he served in various roles at Evogene Ltd., an agriculture biotechnology company, which utilizes a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity, from March 2006 to December 2016, including Executive Vice President of Strategy and Business Development and Executive Vice President of Corporate Development. Prior to joining Evogene, Mr. Oron served as Chief Executive Officer of ChondroSite Ltd., a biotechnology company that develops engineered tissue products in the field of orthopedics and as a senior project manager and strategic consultant at Israeli management consulting company POC Ltd. Mr. Oron holds an M.Sc. in Biology (bioinformatics) and a B.Sc. in Chemistry and Economics, both from Tel Aviv University.

What is the salary of Assaf Oron?

As the Chief Business Officer of BiomX Inc, the total compensation of Assaf Oron at BiomX Inc is $455,692. There are 2 executives at BiomX Inc getting paid more, with Jonathan Solomon having the highest compensation of $936,565.

How old is Assaf Oron?

Assaf Oron is 45, he's been the Chief Business Officer of BiomX Inc since 2019. There are 8 older and 4 younger executives at BiomX Inc. The oldest executive at BiomX Inc is Alan Moses, 72, who is the Independent Director.

What's Assaf Oron's mailing address?

Assaf's mailing address filed with the SEC is C/O BIOMX INC., 22 EINSTEIN ST., FLOOR 4, , NESS ZIONA,, L3, 7414003.

Insiders trading at BiomX Inc

Over the last 5 years, insiders at BiomX Inc have traded over $332,366 worth of BiomX Inc stock and bought 1,036,414 units worth $787,614 . The most active insiders traders include James Edeerfield Management..., Chidozie Ugwumba et Erez Chimovits. On average, BiomX Inc executives and independent directors trade stock every 68 days with the average trade being worth of $533,749. The most recent stock trade was executed by James Edeerfield Management... on 15 July 2024, trading 11,766,000 units of PHGE stock currently worth $11,648,340.

What does BiomX Inc do?

biomx is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (ibd) and cancer. we discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. the company’s platforms use computational and synthetic biology and cutting-edge research from profs. rotem sorek, ph.d., eran elinav, m.d., ph.d., and eran segal, ph.d., of the weizmann institute of science; and professor timothy k. lu, m.d., ph.d., of the massachusetts institute of technology. investors in the company include orbimed israel incubator lp, johnson & johnson development corporation inc., takeda ventures, inc., seventure partners, mirae asset global investments, and sbi.

Complete history of Mr. Oron stock trades at BiomX Inc

BiomX Inc executives and stock owners

BiomX Inc executives and other stock owners filed with the SEC include:

• Jonathan Solomon,
  Chief Executive Officer, Director
• Sailaja Puttagunta,
  Chief Medical Officer
• Assaf Oron,
  Chief Business Officer
• Dr. Merav Bassan Ph.D.,
  Chief Devel. Officer
• Russell Greig,
  Independent Chairman of the Board
• Lynne Sullivan,
  Independent Director
• Paul Sekhri,
  Independent Director
• Alan Moses,
  Independent Director
• Jonas Grossman,
  Independent Director
• Gbola Amusa,
  Independent Director
• Merav Bassan,
  Chief Development Officer
• Marina Wolfson,
  Principal Financial Officer, Vice President - Finance and Operations
• Dr. Regis A. Vilchez M.D., Ph.D.,
  Sr. VP & Head of Clinical Devel.
• Dr. Inbar Gahali-Sass,
  VP of Platform R&D
• Dr. Timothy K. Lu M.D., Ph.D.,
  Scientific Founder
• Dr. Eran Elinav M.D., Ph.D.,
  Scientific Founder
• Inbal Benjamini-Elran,
  VP of HR
• Noel Kurdi,
  VP of Investor Relations & Strategy
• Prof. Timothy K. Lu,
  Scientific Founder
• Dr. Eran Elinav,
  Scientific Founder
• Prof. Rotem Sorek Ph.D.,
  Scientific Founder
• Assaf Oron,
  Chief Bus. Officer
• Yaron Breski,
  Director
• Erez Chimovits,
  Director
• Thomas Layton Walton,
  10% owner
• Eddie Williams,
  Director
• Kerry Mountain Wood Llc Pro...,
  
• Israel Bio Fund Gp Limited ...,
  
• Chidozie Ugwumba,
  
• Susan Blum,
  Director
• Gregory Louis Merril,
  Director
• Jonathan S Leff,
  Director
• Jesse Goodman,
  Director
• James Edeerfield Management...,
  
• Israel Bio Fund Gp Limited ...,
  
• James Edeerfield Management...,
  
• Jason M. Marks,
  Director
• Michael E. Dambach,
  Director
• Fibrosis Foundation Cystic,